Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NexZen Extracts Easter Sale: Get 40% off premium THCa flower using code EASTER40 from April 4–12.
-
GVN Annual Meeting brought together leading virologists, clinicians, public health experts to examine lessons from COVID-19 & share cutting-edge research.
-
Delray Beach, FL, April 02, 2026 (GLOBE NEWSWIRE) -- The global Assisted Reproductive Technology (ART) market is entering a high-growth phase, driven by rising infertility rates, evolving patient...
-
NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- The American healthcare system is at a breaking point, burdening families, employers and government with rising costs while too often failing to deliver...
-
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System
-
Brno, Czechia, April 02, 2026 (GLOBE NEWSWIRE) -- GeneProof, a molecular diagnostics manufacturer and part of NuvinkaDx, announced several significant product and regulatory milestones. The...
-
According to BCC Research, growing demand for compact, lightweight, and high-performance electronic devices is driving strong growth in the FPCB market.
-
If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to progressive, irreversible neurodegeneration...
-
REDWOOD CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...
-
April 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Carla Goulart Peron, MD, Chief Medical Officer at Philips,...